Gr. Sarantis S.A. (ATH:SAR)

Greece · Delayed Price · Currency is EUR

14.80

-0.12 (-0.80%)

Jun 26, 2026, 5:11 PM EET

10.28% (1Y)

Market Cap	936.86M
Revenue (ttm)	599.56M
Net Income (ttm)	53.06M
Shares Out	63.30M
EPS (ttm)	0.83
PE Ratio	17.76
Forward PE	16.17
Dividend	0.39 (2.65%)
Ex-Dividend Date	May 4, 2026

Volume	17,457
Average Volume	30,672
Open	14.84
Previous Close	14.92
Day's Range	14.68 - 14.88
52-Week Range	12.08 - 15.82
Beta	0.54
RSI	42.79
Earnings Date	Sep 8, 2026

About Gr. Sarantis

Gr. Sarantis S.A., together with its subsidiaries, produces and trades in cosmetics, household products, and pharmaceutical items in Greece, Portugal, Poland, Romania, Bulgaria, Serbia, Bosnia and Herzegovina, North Macedonia, Slovenia, Croatia, Czech-Slovakia, Hungary, and Ukraine. It operates through Beauty/Skin/Sun Care, Personal Care, Home Care Solutions, Private Label, and Strategic Partnerships segments. The company offers personal and health care products, including food supplements, health and self-care, baby care, body wash, deodorants... [Read more]

Industry Household & Personal Products

Sector Consumer Staples

Founded 1930

Employees 3,076

Stock Exchange Athens Stock Exchange

Ticker Symbol SAR

Full Company Profile

Financial Performance

In 2025, Gr. Sarantis's revenue was 599.56 million, a decrease of -0.08% compared to the previous year's 600.06 million. Earnings were 53.06 million, an increase of 15.30%.

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for SAR stock is "Strong Buy." The 12-month stock price target is €15.07, which is an increase of 1.82% from the latest price.

Price Target

€15.07

(1.82% upside)

Analyst Consensus: Strong Buy

Stock Forecasts

News

Gr. Sarantis Earnings release: Q1 2026

Gr. Sarantis released its Q1 2026 earnings on April 20, 2026, summarizing the period's financial results.

2 months ago - Filings

Gr. Sarantis Earnings Call Transcript: H2 2025

Profitability surged in 2025 with EBITDA up 9% and net income up 15.3%, driven by strong beauty and sun care growth and international expansion, despite flat sales. Major CapEx and digital investments set the stage for further margin and cash flow improvements in 2026.

3 months ago - Transcripts

Gr. Sarantis Annual report: H2 2025

Gr. Sarantis has published its H2 2025 annual report on March 12, 2026.

3 months ago - Filings

Gr. Sarantis Slides: H2 2025

Gr. Sarantis has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 12, 2026.

3 months ago - Filings

Gr. Sarantis Earnings release: Q3 2025

Gr. Sarantis released its Q3 2025 earnings on October 23, 2025, summarizing the period's financial results.

8 months ago - Filings

Gr. Sarantis Earnings Call Transcript: H1 2025

H1 2025 saw marginal sales growth, but strong double-digit gains in EBITDA, EBIT, and net income, driven by Beauty, Skin Care, and Sun Care. CapEx was revised down, free cash flow and dividends increased, and international expansion—especially in the U.S.—accelerated.

10 months ago - Transcripts

Gr. Sarantis Quarterly report: H1 2025

Gr. Sarantis has published its H1 2025 quarterly earnings report on September 10, 2025.

10 months ago - Filings

Gr. Sarantis Slides: H1 2025

Gr. Sarantis has posted slides in relation to its H1 2025 quarterly earnings report, which was published on September 10, 2025.

10 months ago - Filings